替西罗莫司用于晚期肾细胞癌。 - Suppr

Suppr

超能文献

Temsirolimus for advanced renal-cell carcinoma.

作者信息

Fazio Nicola, Dettori Manuela, Lorizzo Katia

出版信息

N Engl J Med. 2007 Sep 6;357(10):1050; author reply 1050-1. doi: 10.1056/NEJMc071868.

DOI:10.1056/NEJMc071868

PMID:17804854

Abstract

摘要

相似文献

Temsirolimus for advanced renal-cell carcinoma.

N Engl J Med. 2007 Sep 6;357(10):1050; author reply 1050-1. doi: 10.1056/NEJMc071868.

The application of the National Institute of Clinical Excellence guidelines for treatment of metastatic renal cell carcinoma in the United Kingdom: friend or foe?

BJU Int. 2010 Aug;106(4):453-7. doi: 10.1111/j.1464-410X.2010.09466.x. Epub 2010 Jun 22.

New hope for RCC patients.

Eur J Cancer. 2006 Aug;42(12):1693.

Three new drugs available to fight kidney cancer.

J Natl Cancer Inst. 2006 Sep 6;98(17):1181-2. doi: 10.1093/jnci/djj384.

Trials probe new agents for kidney cancer.

JAMA. 2006 Jul 12;296(2):155-7. doi: 10.1001/jama.296.2.155.

Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.

Clin Genitourin Cancer. 2012 Dec;10(4):277-9. doi: 10.1016/j.clgc.2012.04.005. Epub 2012 Jun 1.

Intermittent sunitinib for metastatic renal cell carcinoma.

Lancet Oncol. 2017 Mar;18(3):e139. doi: 10.1016/S1470-2045(17)30082-7. Epub 2017 Feb 3.

Tumour flare during interruption of temsirolimus treatment for metastatic renal cell cancer.

Clin Oncol (R Coll Radiol). 2009 Nov;21(9):732-3. doi: 10.1016/j.clon.2009.07.006. Epub 2009 Aug 7.

[News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors].

Tumori. 2007 Sep-Oct;93(5):Suppl 1-16.

Long-term response with sunitinib for metastatic renal cell carcinoma.

Urology. 2006 Sep;68(3):672.e19-20. doi: 10.1016/j.urology.2006.03.042. Epub 2006 Sep 18.

引用本文的文献

Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results.

Cancers (Basel). 2021 Nov 24;13(23):5896. doi: 10.3390/cancers13235896.

Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy.

Cell Mol Life Sci. 2018 May;75(10):1803-1826. doi: 10.1007/s00018-018-2759-2. Epub 2018 Feb 7.

The challenge of selecting protein kinase assays for lead discovery optimization.

Expert Opin Drug Discov. 2008 Jun;3(6):607-621. doi: 10.1517/17460441.3.6.607.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Temsirolimus for advanced renal-cell carcinoma.

N Engl J Med. 2007 Sep 6;357(10):1050; author reply 1050-1. doi: 10.1056/NEJMc071868.

The application of the National Institute of Clinical Excellence guidelines for treatment of metastatic renal cell carcinoma in the United Kingdom: friend or foe?

BJU Int. 2010 Aug;106(4):453-7. doi: 10.1111/j.1464-410X.2010.09466.x. Epub 2010 Jun 22.

New hope for RCC patients.

Eur J Cancer. 2006 Aug;42(12):1693.

Three new drugs available to fight kidney cancer.

J Natl Cancer Inst. 2006 Sep 6;98(17):1181-2. doi: 10.1093/jnci/djj384.

Trials probe new agents for kidney cancer.

JAMA. 2006 Jul 12;296(2):155-7. doi: 10.1001/jama.296.2.155.

Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.

Clin Genitourin Cancer. 2012 Dec;10(4):277-9. doi: 10.1016/j.clgc.2012.04.005. Epub 2012 Jun 1.

Intermittent sunitinib for metastatic renal cell carcinoma.

Lancet Oncol. 2017 Mar;18(3):e139. doi: 10.1016/S1470-2045(17)30082-7. Epub 2017 Feb 3.

Tumour flare during interruption of temsirolimus treatment for metastatic renal cell cancer.

Clin Oncol (R Coll Radiol). 2009 Nov;21(9):732-3. doi: 10.1016/j.clon.2009.07.006. Epub 2009 Aug 7.

[News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors].

Tumori. 2007 Sep-Oct;93(5):Suppl 1-16.

Long-term response with sunitinib for metastatic renal cell carcinoma.

Urology. 2006 Sep;68(3):672.e19-20. doi: 10.1016/j.urology.2006.03.042. Epub 2006 Sep 18.

引用本文的文献

Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results.

Cancers (Basel). 2021 Nov 24;13(23):5896. doi: 10.3390/cancers13235896.

Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy.

Cell Mol Life Sci. 2018 May;75(10):1803-1826. doi: 10.1007/s00018-018-2759-2. Epub 2018 Feb 7.

The challenge of selecting protein kinase assays for lead discovery optimization.

Expert Opin Drug Discov. 2008 Jun;3(6):607-621. doi: 10.1517/17460441.3.6.607.